换一批
换一批The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 双特异性(Antibodies, Bispecific);腹水(Ascites);综合疗法(Combined Modality Therapy);用药计划表(Drug Administration Schedule);人类(Humans);中年人(Middle Aged);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);穿刺抽液术(Paracentesis)
DOI
10.1002/ijc.25423
PMID
20473913
发布时间
2022-04-08
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
